The Dichotomy of Central Nervous System Cancer Burden: A Global Analysis Revealing Diagnosis-Driven Epidemics and Therapy-Resistant Mortality
Clicks: 3
ID: 320542
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
3 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #5 of 103 articles by views in Neuro-Oncology Advances
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Lay Summary Central nervous system cancers include many different types of brain and spinal cord tumors, and their impact on health is changing around the world. The authors of this study wanted to understand long-term global trends in these cancers and identify the reasons behind differences in diagnosis and survival across regions and tumor types. To do this, they analyzed worldwide and U.S. cancer registry data collected between 1990 and 2021 and compared patterns of new diagnoses and deaths across different tumor subtypes. They found that the number of new cases has increased over time while death rates have changed little overall, with aggressive tumors such as glioblastoma continuing to have poor outcomes despite advances in care, in contrast to less aggressive tumors that are being detected more often.
| Reference Key |
openalex_W7167936205
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Li Guo, H B Hu, Mingying Xiao, Wei Chen, Yuanyang Huang, X Li, Z W Wu, Suixian Zhang, Ying Wang, Baiqiang Dong, C L Wu, Yonggao Mou, Yuanyuan Chen |
| Journal | Neuro-Oncology Advances |
| Year | 2026 |
| DOI |
10.1093/noajnl/vdag171
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.